Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-05-035569
Filing Date
2005-06-20
Accepted
2005-06-20 14:33:20
Documents
1
Period of Report
2005-06-17

Document Format Files

Seq Description Document Type Size
1 rrd83059.html 4  
1 rrd83059.xml 4 6339
  Complete submission text file 0001181431-05-035569.txt   8031
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 15 BLUFF ROAD SOUTH PORTLAND ME 04106
MAXWELL WILLIAM H (Reporting) CIK: 0001208420 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 05905534